TRPV2在心肌缺血再灌注损伤中的作用及干预进展

TRPV2 in Myocardial Ischemia-Reperfusion Injury: Roles and Advances in Intervention

摘要: 心肌缺血再灌注损伤(myocardial ischemia/reperfusion injury, MI/RI)是制约急性心肌梗死再灌注获益的核心瓶颈，钙超载为其关键枢纽。瞬时受体电位香草酸亚型2 (TRPV2)是心脏主要的机械敏感钙通道，兼具动态膜转位与钙通透特，在稳态与病理损伤中作用迥异。本文系统梳理TRPV2的分子特征与“拷贝数–门控”双层调控模式，阐述其在心肌、成纤维细胞及巨噬细胞中响应牵张、生长因子与氧化应激的时空激活规律；重点解析TRPV2介导的病理钙内流如何经calcineurin/NFAT轴、线粒体损伤及炎症–吞噬耦联驱动心肌死亡与不良重构，并归纳粉防己碱、曲尼司特及miR‑202‑5p等靶向策略的干预效应。在此基础上，围绕靶点选择性、再灌注时间窗与细胞偏向性三大转化难点，提出以“降低质膜TRPV2密度”为核心的精准调控方向，为MI/RI的靶向防治提供新思路。

Abstract: Myocardial ischemia/reperfusion injury (MI/RI) remains the principal constraint on reperfusion therapy in acute myocardial infarction, with calcium overload acting as a central pathogenic hub. Transient receptor potential vanilloid 2 (TRPV2) is a major mechanosensitive cation channel in the heart, characterized by Ca²⁺ permeability and activity‑dependent plasma membrane translocation—properties that confer its dual, context‑dependent roles in homeostasis and disease. This review synthesizes current understanding of TRPV2’s structural architecture, regulatory landscape, and “copy number-gating” dual‑layer logic. We delineate its spatiotemporal activation across cardiomyocytes, fibroblasts, and infiltrating macrophages under superimposed mechanical strain, IGF‑1 signaling, and ROS‑mediated Met oxidation. Central to this narrative is how TRPV2‑evoked pathological Ca²⁺ entry drives damage through three convergent pathways: (i) calcineurin/NFAT‑dependent transcriptional reprogramming, (ii) mPTP opening and mitochondrial collapse, and (iii) inflammation-phagocytosis coupling that sustains sterile inflammation. We then appraise emerging interventions—tetrandrine, tranilast, and miR‑202‑5p-mediated silencing—with emphasis on mechanistic insight, efficacy, and translational limitations. Finally, we outline a precision framework that addresses three persistent bottlenecks—TRP‑selective targeting, early reperfusion time window, and cell‑type bias—by prioritizing selective reduction of pathological membrane‑resident TRPV2 over global ablation, thereby uncoupling maladaptive Ca²⁺ amplification from physiological mechanosensing.